Fig. 4From: Investigation of synergistic mechanism and identification of interaction site of aldose reductase with the combination of gigantol and syringic acid for prevention of diabetic cataractAR expression in the lens after treatment with gigantol, syringic acid, and the combination. a Representative image of Western blot, lanes 1 to 5: Group I to Group V. β-actin was used as the internal control. b AR expression levels after normalization for β-actin. The values are mean ± SD (n = 20), *p < 0.01, vs Group I, III, IV, V; **p < 0.05, vs Group III, IVBack to article page